Trying to harness the potential of HDL: wishful thinking or sound strategy?

Eur Heart J. 2014 Dec 7;35(46):3248-9. doi: 10.1093/eurheartj/ehu194. Epub 2014 May 12.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Apolipoprotein A-I / administration & dosage*
  • Cardiovascular Agents / administration & dosage*
  • Coronary Artery Disease / drug therapy*
  • Female
  • Humans
  • Male
  • Phospholipids / administration & dosage*
  • Recombinant Proteins / administration & dosage*

Substances

  • Apolipoprotein A-I
  • Cardiovascular Agents
  • Phospholipids
  • Recombinant Proteins